Similar articles for PMID: 22850602

Year	Number of Results
2000	1
2001	1
2005	2
2006	1
2007	2
2008	3
2009	4
2010	6
2011	20
2012	31
2013	22
2014	27
2015	16
2016	7
2017	4
2018	3
2019	2
2020	1
2024	0

1

Assis DN, Lim JK. Assis DN, et al. Clin Pharmacol Ther. 2012 Sep;92(3):294-305. doi: 10.1038/clpt.2012.103. Epub 2012 Aug 1. Clin Pharmacol Ther. 2012. PMID: 22850602 Review.

2

Future of hepatitis C therapy: development of direct-acting antivirals.

Dore GJ, Matthews GV, Rockstroh J. Dore GJ, et al. Curr Opin HIV AIDS. 2011 Nov;6(6):508-13. doi: 10.1097/COH.0b013e32834b87f8. Curr Opin HIV AIDS. 2011. PMID: 21897228 Review.

3

[Israeli guidelines for the treatment of chronic hepatitis C infection--2012 Israeli Association for the Study of the Liver].

Zuckerman E, Safadi R, Oren R, Shibolet O, Baruch Y, Bruck R, Lurei Y, Kaspa RT, Abu-Mouch S, Shouval D, Ben-Ari Z; Israeli Association for the Study of the Liver. Zuckerman E, et al. Harefuah. 2012 Dec;151(12):709-14, 719. Harefuah. 2012. PMID: 23330266 Hebrew.

4

Boceprevir and telaprevir in the management of hepatitis C virus-infected patients.

Butt AA, Kanwal F. Butt AA, et al. Clin Infect Dis. 2012 Jan 1;54(1):96-104. doi: 10.1093/cid/cir774. Epub 2011 Dec 7. Clin Infect Dis. 2012. PMID: 22156853 Review.

5

Future perspectives: towards interferon-free regimens for HCV.

Gane E. Gane E. Antivir Ther. 2012;17(6 Pt B):1201-10. doi: 10.3851/IMP2431. Epub 2012 Oct 5. Antivir Ther. 2012. PMID: 23186654 Review.

6

New direct-acting antiviral agents for the treatment of hepatitis C virus infection and perspectives.

Welsch C, Jesudian A, Zeuzem S, Jacobson I. Welsch C, et al. Gut. 2012 May;61 Suppl 1:i36-46. doi: 10.1136/gutjnl-2012-302144. Gut. 2012. PMID: 22504918 Review.

7

[Treatment of hepatitis C: current status and perspectives].

Pol S, Corouge M. Pol S, et al. Rev Prat. 2014 May;64(5):605-12. Rev Prat. 2014. PMID: 24923038 French.

8

[Hepatitis C virus: 25 years-old, the end?].

Pol S. Pol S. Med Sci (Paris). 2013 Nov;29(11):998-1003. doi: 10.1051/medsci/20132911016. Epub 2013 Nov 20. Med Sci (Paris). 2013. PMID: 24280503 Free article. Review. French.

9

Will direct-acting antivirals make a difference in HIV-HCV coinfected patients?

Bruno R, Fagiuoli S, Sacchi P. Bruno R, et al. Expert Rev Anti Infect Ther. 2011 Sep;9(9):699-701. doi: 10.1586/eri.11.85. Expert Rev Anti Infect Ther. 2011. PMID: 21905777 No abstract available.

10

[Expert opinion on boceprevir- and telaprevir-based triple therapies of chronic hepatitis C].

Sarrazin C, Berg T, Cornberg M, Dollinger M, Ferenci P, Hinrichsen H, Klinker H, Kraus M, Manns M, Mauss S, Peck-Radosavljevic M, Schmidt H, Spengler U, Wedemeyer H, Wirth S, Zeuzem S. Sarrazin C, et al. Z Gastroenterol. 2012 Jan;50(1):57-72. doi: 10.1055/s-0031-1282015. Epub 2012 Jan 5. Z Gastroenterol. 2012. PMID: 22222799 Review. German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

140 results

Results by year